| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.TP.0000296122.19026.0F |
| P698 | PubMed publication ID | 18162986 |
| P50 | author | Helena Genberg | Q80151939 |
| Annika Wernerson | Q41139346 | ||
| P2093 | author name string | Gunnar Tydén | |
| Lars Wennberg | |||
| Anneli Hansson | |||
| P433 | issue | 12 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rituximab | Q412323 |
| pharmacodynamics | Q725307 | ||
| kidney transplantation | Q740909 | ||
| P304 | page(s) | S33-6 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Pharmacodynamics of rituximab in kidney transplantation | |
| P478 | volume | 84 |
| Q35008036 | A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation |
| Q37676032 | Advances in diagnosing and managing antibody-mediated rejection |
| Q42553965 | Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes |
| Q89288994 | Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient |
| Q104078024 | Effect of Different Rituximab Doses on B Cell Count, Anti-A/B Antibody Titer, Graft Function, and Infectious Complications in ABO-Incompatible Renal Transplantation: A Prospective Study |
| Q41671163 | Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report |
| Q35612362 | Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses |
| Q90242163 | Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab |
| Q36465981 | Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a |
| Q53388671 | Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. |
| Q37078119 | Successful renal transplantation with desensitization in highly sensitized patients: a single center experience |
| Q36943737 | Targeting CD22 reprograms B-cells and reverses autoimmune diabetes |
| Q27021397 | Treatment options and strategies for antibody mediated rejection after renal transplantation |
Search more.